Matthew Walls

Executive Chairman

Matthew was appointed Chairman of Concepta in July 2018 and brings extensive senior and board-level experience in public companies, particularly in pharmaceutical, diagnostics and biotech. Matthew was most recently Chief Executive Officer and Chairman of the leading international patient behavioural change company, Atlantis Healthcare Group from 2015 until 2018.

  Matthew has held Chairman and advisory roles since 2013 for The Fertility Partnership, which has grown to become the UK’s largest fertility group; Matthew was previously Non-Executive Director and Chairman of Artificial Intelligence start-up, BioBeats Group Limited from 2016 until 2018; and Chief Executive Officer of AIM-listed molecular diagnostics company Genedrive Plc between 2007 and 2015, where he led the admission of the Company to AIM with the Company attaining ‘Technology Company of the Year’ in 2009 and 2015.

  Matthew has also held the role of Chief Executive Officer at Oxford Biosignals Limited, Internexus Group Limited and Supanet Limited, and Zylepsis Limited between the years of 2000 and 2006 and was previously Global Commercial Director at the biopharmaceutical company AstraZeneca Plc where he was commercially and financially responsible for strategy and international business operations.
david darrock

David Darrock

Chief Operating Officer

  • > Technical Executive with experience working within highly regulated industries, specializing in operations, continuous improvement and validation.
  • > A professional with wide-ranging expertise and a proven track record in developing and manufacturing medical devices, in the areas of pregnancy, fertility, infectious diseases, blood borne pathogens and drugs of abuse, for consumer and professional brands including Clearblue, Clearview, Persona, TestPack, Cozart DDS and T-SPOT.TB.

Barbara Spurrier

Chief Financial Officer

  • > Fully qualified certified accountant (FCCA) with over 35 years finance experience in numerous sectors
  • > Main board director on four AIM quoted Plc’s, heading the revenue recognition committee of the board for one of these companies

Peter Dines

Non-executive Director

  • > COO and Head of Life Sciences at Mercia Technologies Plc and has particular expertise in commercialising and scaling medtech companies.
  • > Previously MD of obstetric and orthopaedic medical device company Surgicraft before founding and ultimately successfully exiting spinal and orthopaedic implant supplier Surgi C Group.

Adam Reynolds

Non Executive Director

  • > Former stockbroker with over 35 years’ experience within the UK financial services sector
  • > Founded Hansard Group Plc which was admitted to trading on AIM in 2000
  • > Currently a director of several AIM traded companies - non-executive director of EKF Diagnostics Holdings Plc, Optibiotix Plc and Premaitha Health Plc
  • > Director of a number of private companies

Neil Mesher

Non-executive Director

  • Neil has more than 25 years of global experience within the healthcare and consumer electronics industries. He is currently CEO of Philips for the UK and Ireland and is on the Board of the Association of British Healthcare Industries (ABHI), from which he led the industry’s response to the NHS’s “5 Year Forward View”, assessing opportunities for greater integration between industry and the healthcare system. Neil is also a member of the Governments Life Science Industrial Strategy Board, representing the interests of the medical technology sector with other senior leaders from across healthcare.